should employers be able to charge more for health care coverage to employees who do not take part in disease management programs to manage their cholesterol, high blood pressure or diabetes?

1 answer

The question of whether employers should be able to charge more for health care coverage to employees who do not participate in disease management programs, such as those for cholesterol, high blood pressure, or diabetes, is a complex issue involving several considerations:

Pros:

  1. Incentive to Participate: Charging more for non-participation could incentivize employees to engage in programs that may lead to better health outcomes, ultimately benefiting both the individual and the organization.

  2. Cost Management: Employers may face high medical costs associated with untreated chronic conditions. Encouraging participation in disease management programs can potentially lead to lower overall health care costs for employers.

  3. Public Health Value: Improved management of chronic diseases contributes to public health, which can reduce the burden on healthcare systems and potentially improve overall quality of life for individuals.

  4. Shared Responsibility: Employees may need to take greater responsibility for their health. Financial incentives can foster a culture of health awareness and personal accountability.

Cons:

  1. Equity and Access: Not all employees may have equal access to disease management programs, whether due to financial constraints, lack of resources, or other factors. Charging more could disproportionately affect those with fewer resources.

  2. Potential Discrimination: Increased charges could raise ethical concerns about discrimination against individuals based on their health status or participation in wellness programs.

  3. Impact on Employee Morale: Financial penalties for non-participation may lead to resentment among employees, negatively impacting morale and engendering a hostile work environment.

  4. Effectiveness of Programs: The actual effectiveness of disease management programs can vary, and not all employees may respond positively to them. A one-size-fits-all approach may not be appropriate.

Conclusion:

While there are potential benefits to incentivizing participation in disease management programs, there are also significant ethical, equity, and practical concerns that must be carefully weighed. Employers considering such policies should ensure that programs are accessible, effective, and fairly implemented, and they should focus on fostering a supportive health culture rather than simply imposing financial penalties. Additionally, exploring alternative wellness incentives that promote engagement without punitive measures may be a more balanced approach.